Add BrightSurf on Google Email

Antidepressants reduce deaths by more than a third in patients with diabetes

A large population-based study found that antidepressants significantly reduced mortality by 35% in patients with diabetes and depression. This significant reduction highlights the importance of addressing depression in individuals with diabetes, a condition where two to three times more people are at risk of depression.

SourceThe Endocrine Society·JournalThe Journal of Clinical Endocrinology & Metabolism·DateJul 2, 2019

CPAP provides relief from depression

A significant decrease in depression cases was observed after CPAP treatment for sleep apnea in patients with cardiovascular disease. The study found that CPAP treatment had a broader benefit of preventing depression, independent of improved sleepiness.

SourceFlinders University·JournalEClinicalMedicine·DateJul 1, 2019

Parents of depressed teens in treatment may also benefit from counseling

A new Northwestern University study suggests that parents of depressed teenagers should also receive counseling to address their marital relationships and parent-child conflicts. The research found that while the teenager's depression was being treated, parental marriages and conflict remained stable, but worsened after treatment ended.

SourceNorthwestern University·JournalJournal of Abnormal Child Psychology·DateJun 6, 2019

Study could lead to 'cognitive therapy in your pocket'

A study by McLean Hospital researchers shows that CBM-I, a way to change mental habits without visiting a therapist, can be effective when combined with CBT in an acute psychiatric setting. The smartphone app version of CBM-I has great promise for individuals with depression, anxiety, and other mental health conditions, offering on-dem...

SourceMcLean Hospital·JournalBehavior Therapy·DateMay 29, 2019

Social networks and suicide prevention

Depression and mental health problems are spreading through close social networks, with traditional face-to-face contacts unraveling. Experts advocate for 'social prescribing' to engage patients in positive activities within their networks to combat rising suicide rates.

SourceFlinders University·JournalThe Lancet·DateMay 22, 2019

Study supports effectiveness of new fast-acting antidepressant, esketamine nasal spray

A new study published in the American Journal of Psychiatry supports the effectiveness and safety of esketamine nasal spray for treating moderate to severe depression in people who have not responded to previous treatment. The study found significant improvements in depression symptoms within 24 hours of taking the medication.

SourceAmerican Psychiatric Association·JournalAmerican Journal of Psychiatry·DateMay 21, 2019

Nationwide study suggests obesity as an independent risk factor for anxiety and depression in young people

A nationwide study published at the European Congress on Obesity found that children and adolescents with obesity are more likely to develop anxiety or depression compared to their peers. The study, which analyzed over 12,000 Swedish children, revealed a clear increased risk of anxiety and depressive disorders in those with obesity.

For busy medical students, two-hour meditation study may be as beneficial as longer course

A Rutgers-led study found that a two-hour introductory mindfulness class can be just as effective as an eight-week immersive course in reducing stress and depression among medical students. The research suggests that even brief meditation practices can lead to improved mental well-being, making it accessible for time-crunched individuals.

SourceRutgers University·JournalMedical Science Educator·DateApr 15, 2019

Study debunks 'depression genes' hypotheses

A new University of Colorado Boulder study found that the 18 most highly-studied candidate genes for depression are no more associated with it than randomly chosen genes. The research suggests that depression is influenced by many variants, each having a miniscule effect, and challenges previous 'candidate gene hypotheses',

SourceUniversity of Colorado at Boulder·JournalAmerican Journal of Psychiatry·DateApr 2, 2019

Fast-acting psychedelic associated with improvements in depression/anxiety

A Johns Hopkins study found that 80% of participants experienced improvements in anxiety and depression after using synthetic psychedelic 5-MeO-DMT. The short-acting effects of the substance may make it easier to use as an adjunct therapy, with potential benefits for individuals experiencing clinically significant negative mood.

SourceJohns Hopkins Medicine·JournalThe American Journal of Drug and Alcohol Abuse·DateMar 18, 2019